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Csr (carbon storage regulation) of Escherichia coli is a global regulatory system that consists of CsrA, a
homodimeric RNA binding protein, two noncoding small RNAs (sRNAs; CsrB and CsrC) that function as CsrA
antagonists by sequestering this protein, and CsrD, a specificity factor that targets CsrB and CsrC for
degradation by RNase E. CsrA inhibits translation initiation of glgC, cstA, and pgaA by binding to their leader
transcripts and preventing ribosome binding. Translation inhibition is thought to contribute to the observed
mRNA destabilization. Each of the previously known target transcripts contains multiple CsrA binding sites.
A position-specific weight matrix search program was developed using known CsrA binding sites in mRNA.
This search tool identified a potential CsrA binding site that overlaps the Shine-Dalgarno sequence of hfq, a
gene that encodes an RNA chaperone that mediates sRNA-mRNA interactions. This putative CsrA binding site
matched the SELEX-derived binding site consensus sequence in 8 out of 12 positions. Results from gel mobility
shift and footprint assays demonstrated that CsrA binds specifically to this site in the hfq leader transcript.
Toeprint and cell-free translation results indicated that bound CsrA inhibits Hfq synthesis by competitively
blocking ribosome binding. Disruption of csrA caused elevated expression of an hfq-lacZ translational fusion,
while overexpression of csrA inhibited expression of this fusion. We also found that hfq mRNA is stabilized
upon entry into stationary-phase growth by a CsrA-independent mechanism. The interaction of CsrA with hfq
mRNA is the first example of a CsrA-regulated gene that contains only one CsrA binding site.
Bacteria have evolved several regulatory strategies that en-
sure their survival in response to changes in their growth en-
vironment. The Csr (carbon storage regulation) and homolo-
gous Rsm (repressor of secondary metabolites) global
regulatory systems of several eubacterial species control nu-
merous genes and processes posttranscriptionally. Csr systems
consist of at least one RNA binding protein that either acti-
vates or represses expression of target mRNAs, as well as one
or more small noncoding regulatory RNAs (sRNAs) that con-
tain multiple CsrA binding sites. The sRNAs function as an-
tagonists of the RNA binding protein(s) via protein sequestra-
tion (reviewed in references 1 and 26). The Csr system of
Escherichia coli is involved in the repression of several station-
ary-phase processes and the activation of some exponential-
phase functions. Four major components of Csr in this organ-
ism include the homodimeric RNA binding protein CsrA, two
sRNA antagonists of CsrA (CsrB and CsrC), and CsrD, a
protein that specifically targets both sRNAs for degradation by
RNase E (18, 35, 45). CsrA represses gluconeogenesis, glyco-
gen metabolism, peptide transport, and biofilm formation (11,
16, 27, 28, 42, 48), while it activates glycolysis, acetate metab-
olism, and flagellum biosynthesis (28, 43, 44). CsrB and CsrC
sequester CsrA and prevent its interaction with mRNA targets.
Multiple imperfect repeat sequences in these regulatory RNAs
function as CsrA binding sites, such that each sRNA is capable
of sequestering several CsrA dimers (14, 18, 45).
CsrA negatively regulates expression of the glycogen biosyn-
thetic gene glgC by binding to four sites in the untranslated
leader of the glgCAP operon transcript, one of which overlaps
the glgC Shine-Dalgarno (SD) sequence (reference 2 and un-
published results). CsrA binding to the glgCAP leader tran-
script inhibits GlgC synthesis by blocking ribosome binding.
Presumably, CsrA-mediated inhibition of glgC translation is
responsible for the accelerated rate of glgCAP mRNA decay
(19). CsrA also represses translation of cstA, a carbon starva-
tion-induced gene thought to be involved in peptide transport
(11, 31), as well as the first gene in the pgaABCD operon, a
cluster of genes that are required for the synthesis of the
polysaccharide adhesin poly--1,6-N-acetyl-D-glucosamine
(PGA), which participates in biofilm formation (42). CsrA
binds to four sites in the cstA transcript and to six sites in the
pga operon leader transcript. In each case, one of the CsrA
binding sites overlaps the cognate SD sequence. Translational
repression of these genes proceeds by a mechanism that is
similar to the mechanism identified for glgC (11, 42). Consid-
erable sequence variation exists among the known E. coli CsrA
binding sites; however, GGA is a highly conserved sequence
element which is often present in the loop of short RNA
hairpins. Systematic evolution of ligands by exponential enrich-
ment (SELEX) was used to isolate high-affinity CsrA ligands
(10). The high-affinity RNA ligands contained a single CsrA
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binding site with a consensus sequence of RUACARGGA
UGU, with the underlined residues being 100% conserved. In
each case the GGA motif was present in the loop of a short
predicted hairpin (10).
A bioinformatics approach was used to search the E. coli
genomic database for genes containing potential CsrA binding
sites. A potential CsrA binding site was identified that overlaps
the hfq SD sequence, suggesting that CsrA might regulate
translation initiation of this gene. E. coli Hfq is a toroid-shaped
homohexamer that was discovered as a protein required for in
vitro transcription of bacteriophage Q RNA (12, 29). Hfq is
present in a wide range of bacterial species, and its role in
global control of gene expression is readily apparent, as it
impacts numerous physiological processes, such as virulence,
bacteriocin production, and nitrogen fixation (40). Numerous
studies have established that Hfq functions as an RNA chap-
erone in promoting sRNA-mRNA base-pairing (reviewed in
references 13 and 34). For example, it is well established that
Hfq activates translation of S, the stationary-phase sigma
factor, by promoting base-pairing of two sRNAs to the rpoS
leader transcript. Base-pairing of either sRNA disrupts an in-
hibitory RNA structure in the rpoS leader such that translation
is stimulated (13, 23, 34).
We confirmed that CsrA binds to the site in hfq identified in
silico. As this CsrA binding site overlaps the hfq SD sequence,
bound CsrA inhibits translation initiation of hfq by blocking
ribosome binding. The interaction of CsrA with the hfq tran-
script described here is unique, as this is the first example of a
CsrA-regulated mRNA that contains only a single CsrA bind-
ing site. Because Hfq mediates many intermolecular sRNA-
mRNA interactions in the cell, these findings imply that CsrA
has a substantially greater influence on global regulatory net-
works than previously recognized.
MATERIALS AND METHODS
Bacterial strains and plasmids. Plasmid pCSB52 contains the wild-type hfq
leader and the first 55 nucleotides (nt) of the hfq coding region (1 to 124
relative to the start of P3hfq promoter transcription) (37) cloned into the
pTZ18U polylinker (United States Biochemical Corp.). pCSB60 contains an
hfq-lacZ translational fusion consisting of the P3hfq promoter and leader region
as well as the first 18 codons of hfq (66 to 124 relative to the start of P3hfq
transcription), cloned in frame with the lacZ gene of pMLB1034 (32). Three
nucleotide substitutions in the hfq leader just upstream of the SD sequence and
within the CsrA binding site (A51T:T52G:A53C) were introduced into pCSB60
using the QuikChange II protocol (Stratagene), resulting in plasmid pCSB62. E.
coli strains used for -galactosidase assays were constructed to create single-copy
chromosomal gene insertions of hfq-lacZ translational fusions into the  att site
using the InCh protocol as described previously (5). Strains PLB785 and
PLB786 contain the hfq-lacZ fusion from pCSB60 integrated into the chromo-
some of strains CF7789 (MG1655 lacI-Z [MluI]) and TR1-5CF7789 (CF7789
csrA::kan), respectively. Strains PLB923 and PLB924 contain the hfq-lacZ fu-
sion from pCSB62 integrated into the chromosomes of CF7789 and TR1-
5CF7789, respectively. Plasmid pCRA16 (36) contains csrA cloned into pBR322
(4). Strain PLB786 was transformed with pBR322 and pCRA16 to generate
strains PLB789 and PLB793, respectively. Plasmid pYH109 was generated by
replacing the Bacillus subtilis trp operon sequence in pYH28 (30) with a PCR
fragment containing the hfq leader and amino-terminal coding sequence (1 to
179 relative to P3hfq transcription), resulting in an hfq-gfp translational fusion
(37th hfq codon fused in frame with gfp). The E. coli smpB gene was cloned into
the pET28A polylinker (Novagen) to create pETB. Unless otherwise indicated,
all strains were grown at 37°C in Lennox LB medium. When appropriate, growth
media were supplemented with antibiotics to the following concentrations: am-
picillin, 100 g/ml; kanamycin, 50 g/ml; tetracycline, 20 g/ml.
Gel mobility shift assay. Quantitative gel mobility shift assays followed a
previously published procedure (46). E. coli CsrA-H6 protein was purified as
described previously (10). RNA was synthesized in vitro using the MEGAscript
kit (Ambion) and linearized pCSB52 as template. Gel-purified RNA was 5-end
labeled with [	-32P]ATP as described previously (46). RNA suspended in Tris-
EDTA (TE) buffer was renatured by heating to 80°C followed by slow cooling to
room temperature. Binding reaction mixtures (10 l) contained 10 mM Tris-
HCl, pH 7.5, 10 mM MgCl2, 100 mM KCl, 32.5 ng of yeast RNA, 7.5% glycerol,
20 mM dithiothreitol (DTT), 4 U of RNase inhibitor (Promega), 0.5 nM hfq
leader RNA, purified CsrA-H6 (various concentrations), and 0.1 mg/ml xylene
cyanol. Competition assay mixtures also contained unlabeled RNA competitor.
Reaction mixtures were incubated for 30 min at 37°C to allow CsrA-RNA
complex formation. Samples were then fractionated on native 8% polyacryl-
amide gels. Radioactive bands were visualized with a phosphorimager. Free and
bound RNA species were quantified using ImageQuant (Molecular Dynamics),
and the apparent equilibrium binding constant (Kd) of the CsrA-hfq RNA in-
teraction was calculated as described previously (46).
Toeprint assay. Toeprint assays were performed by modifying published pro-
cedures (2, 15). hfq leader transcripts used in this analysis were synthesized using
the MEGAscript kit and linearized pCSB52 as template. Gel-purified hfq leader
RNA (500 nM) in TE was renatured and hybridized to a 5-end-labeled DNA
oligonucleotide (500 nM) in TE that was complementary to the 3 end of the
transcript. Hybridization was accomplished by heating the mixture to 80°C fol-
lowed by slow cooling to room temperature. Toeprint assay mixtures contained
various concentrations of CsrA-H6 and/or 260 nM 30S ribosomal subunits and 5
M tRNAfMet. E. coli ribosomes were purified as described previously (25).
Purified 30S ribosomal subunits were obtained by denaturing 70S ribosomes,
followed by purification through a sucrose gradient. 30S subunit fractions were
pooled and stored at 80°C in 10 mM Tris-HCl, pH 7.5, 60 mM NH4OAc, 6 mM
2-mercaptoethanol, 10 mM MgCl2, and 10% glycerol. Previously frozen 30S
ribosomal subunits were thawed, activated by incubation at 37°C for 15 min, and
kept on ice until addition to toeprint reaction mixtures. Toeprint reaction mix-
tures (20 l) contained 2 l of the hybridization mixture, 375 M each de-
oxynucleoside triphosphate, and 10 mM DTT in toeprint buffer (10 mM Tris-
HCl, pH 7.4, 10 mM MgCl2, 60 mM NH4OAc, 6 mM 2-mercaptoethanol).
Mixtures containing CsrA were incubated for 30 min at 37°C to allow CsrA-
mRNA complex formation. 30S ribosomal subunit toeprint reactions were per-
formed by incubating RNA, 30S ribosomal subunits, and tRNAfMet in toeprint
buffer as described previously (15). Following the addition of 3 U of avian
myeloblastoma virus reverse transcriptase (Roche), the reaction mixture was
further incubated for 15 min at 37°C. Reactions were terminated by the addition
of 12 l of stop solution (70 mM EDTA, 85% formamide, 0.1
 Tris-borate-
EDTA, 0.025% xylene cyanol, and 0.025% bromophenol blue). Samples were
heated at 95°C for 5 min prior to fractionation through standard 6% polyacryl-
amide sequencing gels. Sequencing reactions were performed using pCSB52 as
the template and the same end-labeled DNA oligonucleotide as a primer. Ra-
dioactive bands were visualized with a phosphorimager.
RNA footprint assay. Preparation of 5-end-labeled hfq leader transcripts was
as described for the gel shift analysis. Titrations of RNase T1 (Roche) and RNase
T2 (Sigma) were performed to identify the amount of enzyme in which 90% of
the transcripts were full length to minimize multiple cleavages in any one tran-
script. Binding reaction mixtures (10 l) containing various concentrations of
CsrA-H6 and 50 nM hfq RNA were otherwise identical to those described for the
gel shift assay. After the initial binding of CsrA-H6, either RNase T1 (0.025 U)
or RNase T2 (0.03 U) was added to the reaction mixtures, and incubation was
continued for 15 min at 37°C. Reactions were terminated by the addition of 10
l of gel loading buffer II (Ambion) and kept on ice. Partial alkaline hydrolysis
and RNase T1 digestion ladders of each transcript were prepared as described
previously (3). Samples were fractionated through standard 6% polyacrylamide
sequencing gels. Radioactive bands were visualized with a phosphorimager.
-Galactosidase assays. Bacterial cultures growing in liquid medium at 37°C
were monitored using a Klett-Summerson colorimeter (no. 52 green filter).
Culture samples (4 ml) were harvested at various times, washed once with 10 mM
Tris-HCl, pH 7.5, and frozen as cell pellets at20°C. Cell extracts were prepared
by suspending frozen cell pellets in 0.5 ml of BugBuster protein extraction
reagent (Novagen), followed by incubation at 37°C in an air shaker. After 30 min,
0.3 ml of Z buffer (24) containing 0.2 mg/ml lysozyme was added to each sample,
and incubation was continued for 30 min at 37°C in an air shaker. Cell debris was
removed by centrifugation at 4°C. -Galactosidase assays were performed using
the cell extracts (2, 24). Protein concentrations were determined by the Bio-Rad
protein assay with bovine serum albumin as a standard.
mRNA abundance and mRNA half-life assays. Bacterial cultures were mixed
with 2 volumes of RNAprotect bacterial reagent (QIAGEN) and incubated at
room temperature for 5 min. Cells were then harvested, and total RNA was
prepared using the Masterpure RNA purification kit (Epicenter) and treated
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with DNase I according to the manufacturer’s recommendations. RNA was
quantified by measuring the absorbance at 260 and 280 nm.
To measure hfq transcript levels, strains MG1655 (wild type) and TR1-
5MG1655 (csrA::kan) were grown at 37°C in Lennox LB medium to exponential
phase (optical density at 600 nm of 0.4) or to early stationary phase (optical
density at 600 nm of 4.0). Total RNA was purified, and the steady-state level of
hfq mRNA was determined by real-time quantitative reverse transcription-PCR
(RT-qRT-PCR) using the primer pair hfq-Fw (5-AAGCACGCGATTTCTAC
TGTTG-3) and hfq-Rv (5-CCACCGGCGTTGTTACTGT-3) and the probe
Hfq-6FAM-BHQ1 (5-CCCGTCTCGCCCGGTTTCTCA-3), which was 5-end
labeled with 6-carboxyfluorescein (6FAM) and 3-end labeled with Black Hole
Quencher 1 (BHQ1). RT-qRT-PCR was performed using the iScript one-step
RT-PCR kit for probes (Bio-Rad) with a Bio-Rad iCycler IQ real-time system.
The conditions used for RT-PCR were as follows: 50°C for 10 min, 95°C for 5
min, and 40 cycles of 95°C for 15 s and 65°C for 30 s. Unless otherwise noted, all
primers and probes were used at a final concentration of 200 nM. Real-time
measurements were taken during the 65°C step. Reactions were performed in
triplicate in two independent experiments, each time with 100 ng of template
RNA. A set of reactions lacking reverse transcriptase was performed for each
RNA sample as a control for DNA contamination. For normalization of
hfq RNA levels, RT-qRT-PCRs were performed with each sample for 16S rRNA
quantitation using the primer pair 16S-Fw (5-CGTGTTGTGAAATGTTGGG
TTAA-3) and 16S-Rv (5-CCGCTGGCAACAAAGGATA-3) and the probe
16S-6FAM-BHQ1 (5-TCCCGCAACGAGCGCAACC-3). The reaction condi-
tions for RT-qRT-PCR of 16S rRNA were identical to hfq except that 1 ng of
RNA template was used for each reaction. The 2CT method was used to
calculate relative hfq RNA levels, which allowed for the use of a 16S rRNA
control (20).
For hfq mRNA half-life studies, strains MG1655 (wild type) and TR1-
5MG1655 (csrA::kan) were grown as described above. Cells were harvested at
various times following the addition of rifampin (200 g/ml final concentration),
and total RNA was purified as described above using RNAprotect. RT-qRT-
PCR was performed as described above for steady-state hfq RNA determina-
tions. The percentage of RNA remaining through the time course was deter-
mined by calculating the difference in cycle threshold (CT) and the subsequent
fold difference compared to the 0-min time point after controlling for 16S rRNA
levels.
RNA-directed cell-free translation. Cell-free translation reactions followed
previously published procedures (9, 47). Transcripts for this analysis were syn-
thesized using the Ambion MEGAscript kit. hfq-gfp and smpB transcripts were
synthesized using linearized pYH109 and pETB as templates, respectively. bla
was transcribed from a 1,020-nt PCR fragment containing a T7 promoter. CsrA-
deficient E. coli S-30 extract was prepared from TR1-5 MG1655 (csrA::kan)
according to published procedures (47). The S-30 extract was preincubated with
RNase-free DNase I for 15 min at 37°C to remove chromosomal DNA and to
allow time for E. coli RNases to degrade endogenous mRNA. Reaction mixtures
(24 l) contained 60 mM Tris-HEPES, pH 7.5, 60 mM NH4Cl, 5 mM to 15 mM
MgCl2 (determined empirically for each transcript), 12 mM KCl, 0.5 mM EGTA,
5 mM DTT, 2 mM ATP, 0.6 mM GTP, 0.08 mM calcium folinate, 4 mg/ml of
aprotinin, 4 mg/ml of leupeptin, 4 mg/ml of pepstatin A, 4 l S-30 extract (12 mg
of total protein), 800 U/ml of DNase I, 500 U/ml of RNasin, 10 mM phos-
phoenolpyruvate, 35 U of pyruvate kinase, 0.4 mg/ml of E. coli tRNA, 0.04 g/ml
of mRNA, 10 Ci [35S]methionine, 0.5 mM of each of the other amino acids, and
0.8 mM spermidine. Reaction mixtures were incubated for 45 min at 37°C and
terminated by adding 6 l of stop buffer (125 mM Tris-HCl, pH 6.8, 5% sodium
dodecyl sulfate [SDS], 25% glycerol, 2% 2-mercaptoethanol, and 12.5 mg/ml of
bromophenol blue). Samples were heated at 95°C for 5 min prior to fractionation
by 14% SDS-polyacrylamide gel electrophoresis (PAGE). Radioactive bands
were visualized with a phosphorimager and quantified using ImageQuant.
RESULTS
Identification of hfq as a potential CsrA-regulated gene. A
genome search program was developed to identify potential
CsrA binding sites by exploring the properties of known CsrA
binding motifs. A total of 14 CsrA binding sites were previously
identified in the leader regions of glgC, cstA, and pgaA (refer-
ences 2, 11, and 42 and unpublished results). These sequences
were aligned using ClustalW (7), and a position weight matrix
(pwm) was calculated from the alignment using the MATCH
tool (17). The pwm was then used as a scoring function to
identify potential CsrA binding sites within the E. coli genomic
database. The scores were assigned from 0 to 100% according
to the minimum and the maximum score calculated from the
pwm. The details of the pwm will be published elsewhere. This
program predicted the presence of CsrA binding sites in 278
genes with scores of 96.5% or above, including the three genes
that were used in generating the pwm (cstA, glgC, and pgaA). A
CsrA binding site with a score of 96.8% was identified that
overlaps the hfq SD sequence. This predicted sequence also
conformed to the SELEX-derived consensus sequence in 8 out
of 12 positions (Fig. 1). However, unlike the CsrA binding sites
identified by SELEX, secondary structural predictions using
MFOLD (49) indicated that the GGA motif within this puta-
tive CsrA binding site was not present in the loop of a hairpin.
The pwm also identified three potential sites with scores be-
tween 81.8 and 83.5%; however, since all three of these sites
overlapped the predicted site with a score of 96.8% and none
of them contained an appropriately positioned GGA motif, it
appeared that hfq contained one likely CsrA binding site. Be-
cause all of the known CsrA-controlled genes contained four
to six CsrA binding sites, experiments were carried out to
determine whether hfq contained a single CsrA binding site
and whether CsrA could bind to this site in hfq and regulate its
expression.
CsrA binds to the predicted site in hfq. hfq transcription is
driven by three promoters just upstream of its coding se-
quence. The hfq transcript originating from the SD sequence-
proximal P3 promoter (P3hfq) contains a 68-nt untranslated
leader (37). To characterize the interaction of CsrA with hfq
RNA, quantitative gel mobility shift assays were performed
with an hfq transcript containing nucleotides 1 to 124 rel-
ative to the start of P3hfq transcription. Since quantitative gel
mobility shift assays using native CsrA or C-terminal His-
tagged CsrA (CsrA-H6) did not show any significant difference
in binding affinities for target transcripts (data not shown),
CsrA-H6 was used in all in vitro assays and is referred to as
CsrA from here on. CsrA bound to this hfq transcript as a
distinct band in native gels between 4 and 512 nM CsrA (Fig.
2A). A complete shift was observed at 128 nM CsrA, and no
additional shifted species of higher molecular weights were
observed as the concentration of CsrA was increased further,
suggesting that CsrA binds to a single site in the hfq leader
transcript. A nonlinear least-squares analysis of these data
yielded an estimated Kd value of 38  13 nM CsrA (mean 
standard deviation). For comparison, the affinities of CsrA for
glgC (four CsrA binding sites), cstA (four CsrA binding sites),
and pgaA (six CsrA binding sites) were 39 nM, 40 nM, and 22
nM, respectively (2, 11, 42).
The specificity of the CsrA-hfq RNA interaction was inves-
FIG. 1. Predicted CsrA binding site overlapping the hfq SD se-
quence. The SELEX-derived CsrA binding site consensus sequence is
shown above the predicted CsrA binding site in hfq mRNA. Vertical
lines mark the residues in the predicted site that match those in the
consensus. Positions of the hfq SD sequence and translation initiation
codon (Met) are shown.
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tigated by performing competition experiments with specific
(hfq leader and a SELEX-derived ligand) and nonspecific (Ba-
cillus subtilis trp leader) unlabeled RNA competitors (Fig. 2B).
Unlabeled hfq and SELEX transcripts were effective compet-
itors, whereas the B. subtilis trp leader RNA (trpL) did not
compete with the CsrA-hfq RNA interaction. These results
establish that CsrA binds specifically to hfq RNA.
CsrA-hfq RNA footprint experiments were conducted to
identify the position of bound CsrA in the hfq transcript. Sin-
gle-strand-specific RNases were used as probes for these stud-
ies. As the concentration of CsrA was increased from 0 to 2
M, protection of several nucleotides from RNase T1 (G spe-
cific) and RNase T2 (A preference) cleavage was observed
(Fig. 3A). CsrA protected G49, G57, and G58 from RNase T1
cleavage, as well as residues A51 through A61 from RNase T2
cleavage. Importantly, the entire sequence overlapping the hfq
SD sequence identified in silico was protected from RNase
cleavage. The composite footprint indicates that CsrA protects
one RNA segment extending from G49 through A61 (Fig. 3B).
Previous RNA structure mapping identified two stable RNA
hairpins in the hfq transcript (h1 and h2) (41). The presence of
these hairpins was confirmed; residues corresponding to h1
and h2 were protected from RNase cleavage in the absence of
bound CsrA (Fig. 3). Bound CsrA also resulted in increased
RNase T2 cleavage of C20 and C42. These two residues are
located within the 5 side bulge of h1 and just downstream of
h1, respectively. CsrA-dependent protection was also observed
for residues A76 (RNase T2), G77 (RNase T1), and G78
(RNase T1). These residues are present within the stem of a
predicted RNA hairpin containing a GNRA tetraloop (G,
4.0 kcal/mol) (22, 49). Thus, it appears that bound CsrA
stabilizes this structure (Fig. 3).
Bound CsrA inhibits translation initiation of hfq. Primer
extension inhibition (toeprint) experiments were performed to
determine whether CsrA was capable of competing with 30S
ribosomal subunits for binding to the hfq transcript. The pres-
ence of bound CsrA or 30S ribosomal subunits should stop
primer extension by reverse transcriptase, resulting in a
toeprint band near the 3 boundary of the bound macromole-
cule. Stable secondary structures are also capable of inhibiting
extension by reverse transcriptase, resulting in a toeprint band
near the 3 end of the RNA hairpin. The toeprint results are
presented in Fig. 4 and summarized in Fig. 3B. The presence of
CsrA resulted in toeprints at positions A43, A82, and A91. The
toeprint at A91 provides additional evidence for the hairpin
containing the GNRA tetraloop, as this structure ends at A89
(Fig. 3B). The toeprint at A43 likely corresponds to the base of
h1, as this RNA hairpin ends at G39. The origin of the A82
toeprint is unclear, as it is not near the 3 end of a stable
hairpin and is 21 nt downstream from the 3 end of the CsrA
footprint (Fig. 3 and 4). Since a toeprint corresponding to the
3 boundary of bound CsrA was not observed, it appears that
reverse transcriptase is effective at displacing CsrA when
bound to a single site.
Toeprint assays were also performed to identify the posi-
tions of bound 30S ribosomal subunits. A prominent
tRNAfMet-dependent 30S ribosomal subunit toeprint band was
observed 15 nt down from the A of the AUG initiation codon,
which is the same distance from the translation initiation
codon as was previously observed for several mRNAs (2, 11,
42, 47). The second 30S ribosomal subunit-dependent toeprint
at G72 was not expected, and its origin is unknown. Toeprint
experiments were also carried out to determine whether bound
CsrA could inhibit ribosome binding. Importantly, when CsrA
was bound to the hfq transcript prior to the addition of 30S
ribosomal subunits and tRNAfMet, each of the CsrA-depen-
dent toeprint bands was observed, whereas the 30S ribosomal
subunit toeprint bands were eliminated (Fig. 3B and 4). Thus,
our toeprinting results demonstrate that bound CsrA prevents
ribosome binding to the hfq transcript, suggesting that CsrA
could be capable of preventing translation initiation and Hfq
synthesis.
FIG. 2. Gel mobility shift analysis of the CsrA-hfq RNA interaction. 5-end-labeled hfq RNA was incubated with the concentration of CsrA
shown at the bottom of each lane. Gel shift assays were performed in the absence (A) or presence (B) of various unlabeled competitor RNAs. The
concentration of each competitor RNA is shown at the bottom of each lane in panel B. The positions of bound (B) and free (F) hfq RNA are shown
at the left of each gel. (A) Determination of the equilibrium binding constant of the CsrA-hfq RNA interaction. The simple binding curve for these
data is shown at the right. (B) Competition assay for the CsrA-hfq RNA interaction to establish binding specificity. Lanes corresponding to
competition with specific (hfq and SELEX) and nonspecific (trpL) RNAs are indicated.
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Since our in vitro binding studies demonstrated that bound
CsrA blocks ribosome binding, RNA-directed cell-free trans-
lation experiments were conducted to determine whether CsrA
inhibits Hfq synthesis (Fig. 5). Our initial attempt to examine
the effect of CsrA on Hfq synthesis was problematic, as we
observed multiple bands, suggesting that hexameric Hfq was
not completely denatured (data not shown). Because we pre-
viously found that using gfp translational fusions circumvented
similar problems in cell-free translation experiments with B.
subtilis S-30 extracts, an hfq-gfp translational fusion transcript
was tested in the E. coli S-30 extract. In this case, well-behaved
Hfq-Gfp fusion polypeptides were produced that migrated as a
doublet. Importantly, addition of increasing concentrations of
CsrA to the cell-free translation system led to a corresponding
decrease in the Hfq-Gfp synthesis (Fig. 5). Similar cell-free
translation experiments were carried out using smpB and bla
transcripts as negative controls. The smpB transcript contained
an SD sequence derived from pET28A, whereas the bla tran-
script contained its natural SD sequence. Slight CsrA-depen-
dent translation inhibition was observed for the negative con-
trols, although the level of inhibition was far less than for
Hfq-Gfp (Fig. 5). These results, in conjunction with the in vitro
binding studies, demonstrate that CsrA inhibits translation ini-
tiation of hfq by blocking ribosome access to the hfq transcript.
As Hfq was previously shown to repress its own translation
(41), it was of interest to determine whether CsrA- and Hfq-
mediated translation control is additive. Results from cell-free
translation experiments confirmed that Hfq represses its own
translation (Fig. 5C and data not shown). Moreover, an addi-
tive effect of CsrA and Hfq on translation inhibition was ob-
served at protein concentrations of 0.8 M (Fig. 5C). This
latter result was somewhat surprising, as one of the Hfq bind-
ing sites overlaps the single CsrA binding site.
CsrA inhibits hfq expression. CsrA-dependent regulation of
hfq was examined in vivo using an hfq-lacZ translational fu-
sion whose expression was driven by P3hfq (37). This fusion was
FIG. 3. CsrA-hfq RNA footprint analysis. (A) hfq RNA was treated with RNase T1 or RNase T2 in the absence or presence of CsrA. The
concentration of CsrA used is indicated at the top of each lane. Partial alkaline hydrolysis (OH) and RNase T1 digestion (T1) ladders, as well as
control (C) lanes in the absence of RNase treatment, are shown. The RNase T1 ladder was generated under denaturing conditions so that every
G residue in the transcript could be visualized. Residues in which RNase cleavage was reduced () or enhanced () in the presence of CsrA are
marked. The positions of the CsrA footprint (FP), the hfq SD sequence, and the translation initiation codon (AUG) are shown. Two RNA
segments corresponding to RNA secondary structures (h1 and h2) that were previously identified are shown (41). Numbering at the left of each
gel is from the start of hfq transcription. (B) Summary of the hfq footprint results (from panel A) and toeprint results (from Fig. 4, below). The
composite CsrA footprint shows the residues in which cleavage was reduced () or enhanced () by the presence of bound CsrA. Residues
corresponding to the CsrA-dependent and 30S ribosomal subunit (Rib) toeprints are marked with arrowheads. An additional 30S ribosomal
subunit-dependent toeprint is marked (). The positions of the hfq SD sequence and translation initiation codon (Met) are indicated. Inverted
horizontal arrows identify the residues corresponding to h1, h2, and a short RNA hairpin containing a GNRA tetraloop. Vertical arrows identify
a triple nucleotide substitution introduced into the CsrA binding site. Numbering is from the start of hfq transcription.
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integrated into the lambda att site of the E. coli chromosome in
single copy, and expression was examined throughout the
growth curve in both wild-type and csrA mutant backgrounds.
When compared to the wild-type strain, a small but reproduc-
ible increase in expression (30%) was observed in the csrA
mutant during stationary-phase growth (Fig. 6A). Expression
was also examined when cells were grown in LB plus 1%
glucose, because we previously found that expression of a
cstA-lacZ fusion in wild-type and mutant strains differed to a
greater extent under this glycolytic growth condition (11). A
somewhat higher increase in expression (50%) was observed
in the csrA mutant from the late exponential to the stationary
phase of growth when cells were grown in LB plus 1% glucose
(Fig. 6C). Introduction of csrA on a plasmid complemented the
csrA mutant defect, resulting in a twofold reduction of hfq-
lacZ expression beginning in late exponential phase (Fig. 6B).
We attempted to examine the influence of a mutant CsrA
binding site on hfq expression. Because the critical GGA motif
in this binding site is part of the hfq SD sequence, three CsrA
binding site residues located just upstream from the hfq SD
sequence were altered (A51T:T52G:A53C) (Fig. 3B). Expres-
sion from this mutant fusion was reduced 5-fold in both
wild-type and csrA mutant strains (Fig. 6C), suggesting that
sequence alterations this close to the SD sequence had dele-
terious effects on translation initiation. Furthermore, it is ap-
parent that these substitutions did not eliminate CsrA-depen-
dent inhibition of hfq expression, suggesting that a more
substantial change to the CsrA binding site would be needed to
prevent the CsrA-hfq RNA interaction. While the reason for
reduced translation of the binding site mutant is not known,
RNA secondary structure predictions using MFOLD (49) sug-
gest that RNA structural rearrangements are not the cause.
Previous studies established that the mRNAs of several
CsrA-repressed genes were stabilized in csrA mutant strains (1,
26). The steady-state level of hfq mRNA was determined by
RT-qRT-PCR in wild-type and csrA mutant strains in the ex-
ponential and early stationary phases of growth. The relative
abundance of hfq mRNA was 2-fold and 1.7-fold higher in the
csrA mutant strain during exponential and early stationary
phases of growth, respectively. The increased level of hfq
mRNA in the csrA mutant strain could have been caused by
increased transcription or a reduction in the mRNA decay
rate. Results from mRNA half-life experiments indicated that
CsrA does not affect the stability of hfq mRNA, suggesting that
CsrA indirectly influences hfq transcription (Fig. 7). While the
half-life of hfq mRNA was similar in wild-type and csrA mutant
strains, we found that hfq transcripts were dramatically stabi-
lized in the early stationary phase of growth (Fig. 7). Thus, it
appears that mRNA stabilization contributes to increased hfq
expression in stationary phase by a CsrA-independent mecha-
nism.
DISCUSSION
CsrA is a global regulatory RNA binding protein that re-
presses or activates gene expression posttranscriptionally.
Bound CsrA inhibits expression of several genes by binding to
multiple sites within target transcripts, one of which overlaps
the cognate SD sequence, thereby blocking ribosome binding.
Inhibition of translation is thought to contribute to the ob-
served accelerated rate of mRNA decay (1, 26). In the case of
gene activation, bound CsrA can stabilize target transcripts,
although the mechanism of message stabilization is not known
(43). Two sRNA antagonists of CsrA, CsrB and CsrC, contain
multiple CsrA binding sites and function by sequestering this
protein (18, 45). Expression of csrA, csrB, and csrC increases as
the culture approaches stationary phase (14, 45). The BarA/
UvrY two-component signal transduction system activates
transcription of csrB and csrC (36). Although the signal for this
activation is not known, BarA signaling appears to be pH
dependent (21). Interestingly, CsrA indirectly activates synthe-
sis of both of the sRNAs via the response regulator UvrY,
resulting in an autoregulatory circuit for CsrA, CsrB, and CsrC
(36, 45). A fourth Csr component, the CsrD protein, was re-
cently shown to be a specificity factor that targets CsrB and
CsrC for degradation by RNase E (35). As CsrA acts down-
stream of transcriptional regulation and generally affects gene
FIG. 4. CsrA and 30S ribosomal subunit toeprint analysis of hfq
RNA. The concentration of CsrA used in each reaction mixture, as
well as the absence () or presence () of tRNAfMet and 30S ribo-
somal subunits (30S Rib), is shown at the top of each lane. CsrA was
added prior to 30S ribosomal subunits when both were present in the
same reaction mixture. Arrows identify CsrA-dependent and 30S ri-
bosomal subunit (Rib) toeprint bands. An additional 30S ribosomal
subunit-dependent toeprint is marked (). Positions of the hfq SD
sequence and the translation initiation codon (AUG) are shown. The
RNA segment corresponding to h1 is also shown. Sequencing lanes to
reveal G, U, A, or C residues are marked. Numbering is from the start
of hfq transcription.
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expression in the 1.5- to 10-fold range (11, 19, 27, 42, 43), it
appears that CsrA functions in a fashion similar to a “gover-
nor” on a motor by reducing expression of some genes and
increasing expression of others, rather than as an on-off switch.
A pwm search tool identified a potential CsrA binding site
that overlaps the hfq SD sequence. The finding that this single
site was similar to the SELEX-derived binding site consensus
(Fig. 1) led us to investigate CsrA-dependent regulation of this
gene. hfq is located in the amiB-mutL-miaA-hfq-hflX super-
operon, which contains both E32- and E70-specific promot-
ers (37, 38). Transcription of this operon is driven by at least
five promoters during exponential growth (PmutL, PmiaA, P1hfq,
P2hfq, and P3hfq). Our studies focused on the 68-nt mRNA
leader originating from the SD sequence-proximal promoter,
P3hfq. Our gel shift (Fig. 2) and footprint (Fig. 3) results dem-
onstrate that CsrA binds to the single site identified in silico.
Moreover, the toeprint (Fig. 4) and cell-free translation (Fig.
7) results establish that bound CsrA inhibits Hfq synthesis by
competitively blocking ribosome binding. While hfq mRNA
contains only a single CsrA binding site, the affinity of the
CsrA-hfq RNA interaction (Kd, 38 nM) is comparable to the
affinity that CsrA has for mRNAs containing four to six binding
sites (Kd, 22 to 40 nM). Despite the high affinity for hfq RNA,
CsrA-mediated regulation was only 1.5- to 2-fold under our
growth conditions (LB and LB plus glucose) (Fig. 5). This level
of regulation is comparable to CsrA-dependent regulation of
cstA expression in LB; however, regulation of cstA was 5-fold
in LB plus glucose (11). Thus, it is possible that growth con-
ditions for optimum CsrA-dependent regulation of hfq were
not achieved.
The finding that translational repression did not alter the
stability of hfq mRNA constitutes the first example in which
CsrA-mediated translational repression did not lead to accel-
erated mRNA decay (Fig. 6). The observation that CsrA did
not influence the stability of hfq mRNA, combined with the
finding that the steady-state level of hfq transcripts was ele-
vated in csrA mutant strains, suggests that CsrA has a negative
effect on hfq transcription as well as translation. While CsrA
caused only a small reduction in expression of the hfq-lacZ
fusion used in this study, it is important to note that our fusion
contained only one of five known hfq promoters, P3hfq. Since it
is reasonable to assume that CsrA is capable of repressing
translation initiation of transcripts derived from any of the hfq
promoters, it appears likely that CsrA indirectly represses tran-
scription from (at least) one of the other hfq promoters. Thus,
the in vivo effect of CsrA on translation, as determined by the
hfq-lacZ reporter, and the apparent indirect effect of CsrA on
FIG. 5. Effect of CsrA and Hfq on in vitro translation of hfq-gfp mRNA. The E. coli S-30 extract was prepared from a CsrA-deficient strain.
(A) Reactions were carried out with the concentration of CsrA indicated at the top of each lane in the absence () or presence () of hfq-gfp
or control (smpB or bla) transcripts. Hfq-GFP, SmpB, and Bla translation products were analyzed by SDS-PAGE. (B) Relative levels of Hfq-GFP,
SmpB, and Bla polypeptide synthesis as a function of CsrA concentration. All of the bands shown in panel A were used for quantifying the effect
of CsrA on protein synthesis. The level of polypeptide synthesis in the absence of CsrA was set to 1.0 for each transcript. (C) Reactions were carried
out with the concentration of CsrA and/or Hfq indicated at the top of each lane in the absence () or presence () of hfq-gfp transcripts.
Hfq-GFP products were analyzed by SDS-PAGE. The relative level of polypeptide synthesis is shown at the bottom of each lane. The level of
polypeptide synthesis in the absence of CsrA and Hfq was set to 100.
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hfq mRNA transcription, as determined by RT-qRT-PCR,
likely contribute to the overall effect of CsrA on Hfq levels.
All previously characterized CsrA target mRNAs contain
four or more CsrA binding sites (references 2, 11, 18, 42, and
45 and unpublished results). As CsrA is not a general repressor
of translation, the finding that CsrA is capable of inhibiting
translation of an mRNA containing a single CsrA binding site
that overlaps its cognate SD sequence raises the question of
how CsrA distinguishes one SD sequence from another. RNA
secondary structure does not appear to be the only answer, as
the majority of the known CsrA binding sites in mRNA targets,
including the single binding site in hfq, do not contain their
GGA motif in the loop of an RNA hairpin. Thus, additional
conserved RNA sequence elements of binding sites must con-
tribute to binding specificity.
Hfq is known to inhibit its own translation by binding to two
sites within the hfq leader and initially translated region (41).
Site A is located just upstream of the h1 hairpin, while binding
site B overlaps its SD sequence (Fig. 3B). Both CsrA and Hfq
are effective at inhibiting formation of a translation initiation
complex. As Hfq-mediated autoregulation was reported to be
about twofold, it is apparent that the level of CsrA-dependent
and Hfq-dependent inhibition of hfq translation is similar.
Moreover, it appears that CsrA-dependent and Hfq-depen-FIG. 6. CsrA-dependent regulation of an hfq-lacZ translational fu-
sion. Cells were harvested at various times throughout growth and assayed
for -galactosidase activity. Growth medium was LB (A and B) or LB
supplemented with 1% glucose (C). Growth curves for each strain in
panels A, B, and C were essentially identical. The time shown is hours of
cell growth. These experiments were conducted at least three times with
similar results. Results from representative experiments are shown. (A) -
Galactosidase activity was determined for PLB785 (wild type [WT]) and
PLB786 (csrA::kan). Cell growth was measured in strain PLB785. (B) -
Galactosidase activity was determined for PLB793 (csrA::kan/pCRA16
[WT]) and PLB789 (csrA::kan/pBR322 [csrA]). Cell growth was measured
in strain PLB789. (C) -Galactosidase activity was determined for
PLB785 (WT, WT fusion), PLB786 (csrA::kan [csrA, WT fusion]),
PLB923 (WT with mutant hfq-lacZ fusion), and PLB924 (csrA::kan
[csrA] with mutant hfq-lacZ fusion). Cell growth was measured in
strain PLB785.
FIG. 7. Effects of growth phase and CsrA on hfq mRNA stability.
hfq mRNA half-lives were determined in wild-type (WT) and csrA
mutant strains during the exponential and early stationary phases of
growth. The relative levels of mRNA remaining at 0, 1, 2, 4, 8, 15, and
32 min after the addition of rifampin were determined by RT-qRT-
PCR. The mRNA level corresponding to each 0-min time point was set
to 100. The mRNA half-life for each strain and growth phase is shown
next to the corresponding symbol. Strains used were MG1655 (wild
type) in exponential phase (WT-exp), TR1-MG1655 (csrA::kan) in
exponential phase (csrA-exp), MG1655 in early stationary phase (WT-
stat), and TR1-MG1655 in early stationary phase (csrA-stat).
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dent inhibition of Hfq synthesis is additive despite the fact that
the CsrA binding site and Hfq binding site B overlap (Fig. 5C).
Additional studies further establish an interrelationship be-
tween CsrA and Hfq. A global analysis of protein-protein in-
teractions in E. coli using Hfq as the “bait” protein identified
a stable interaction with CsrA (6). The intracellular levels of
Hfq hexamers and CsrA dimers were determined to be ap-
proximately 9,000 and 16,000 molecules, respectively (14, 39).
The mRNA signal intensity from a transcription profile of cells
grown in minimal medium showed that the relative hfq tran-
script level (11,884) was comparable to that of csrA (7,783) (8).
An additional study reported that Hfq stabilized RsmY RNA,
a CsrB homolog in Pseudomonas aeruginosa (33). Moreover,
that study suggested that RsmA, a CsrA homolog, and Hfq
could bind concurrently to RsmY, a known antagonist of
RsmA.
Csr and homologous Rsm systems have been identified in a
wide variety of bacterial species (1, 26). Depending on the
particular organism, this global regulatory system controls a
variety of cellular processes and behaviors (e.g., RpoS stress
signaling, quorum sensing, biofilm development, motility and
chemotaxis, central carbon flux, and pathogenesis). The finding
that the Csr circuitry is interconnected with other global reg-
ulatory networks suggests that Csr governs cellular behavior
and physiology on a scale that is not yet fully understood.
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